Cynosure’s New Life After Hologic Includes a Merger

Nearly five years ago, Cynosure was divested from Hologic. Underperformance led the Waltham, MA-based firm to shed Cynosure, a medical aesthetics company.

Cynosure has just recently undergone another change. The medical aesthetics company has merged with Lutronic, another provider of energy-based medical aesthetics treatment systems. The merger was first announced in January.

Lutronic is owned by Hahn & Company, a private equity firm operating in Korea. The merged company is called Cynosure Lutronic.

"Uniting Cynosure and Lutronic signifies a bold step towards reshaping the landscape of medical aesthetics. This merger embodies our collective dedication to pushing boundaries and ensuring excellence in customer experience," said Nadav Tomer, who will be CEO of the newly merged entity.

In addition to Tomer as CEO, the Cynosure Lutronic Executive Leadership Team also includes Bob Howe as CFO; DenaRae Walter as Chief Human Resources Officer; Sean Flanagan as Chief Legal Officer; Jae Hoon Yoo as COO; Lowinn Kibbey as President of North America; Hauke Harms as President of International; Hyun Min Shin as SVP of R&D; Yoon Dong Kim as Chief Integration Officer; and Nirav Desai as VP, Regulatory Affairs & Quality Assurance.

 The company said the merger will allow it to have a commercial presence in more than 130 countries. The company also noted that it would have a reinforced supply chain to ensure seamless continuity of products and services.

Related:All Eyes on Hologic’s Earnings After Cynosure Split